Videos

Mechanical thrombectomy beats anticoagulation alone in STORM-PE
Highly anticipated trial data comparing mechanical thrombectomy to anticoagulation alone for intermediate- and high-risk pulmonary embolism showed that the more aggressive strategy improved outcomes.
ACC raises red flags over telehealth, payment reform and the cardiologist shortage
"We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted."
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
The push to get 3D echo into the congenital operating room
Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.
Nuclear cardiology expands beyond perfusion imaging as it enters a new era
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.

Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.

A closer look at GE HealthCare's new affordable cardiac CT scanner

As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.

Dean Kereiakes, a nationally renowned interventional cardiologist and president of The Christ Hospital Heart and Vascular Institute, has long been recognized for his groundbreaking work in cardiovascular research and intervention. But in 2024, his career and his life were permanently altered when decades of wearing heavy lead protection in the cath lab left him paralyzed.

Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back

Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.

Paul Ridker, MD, MPH, Eugene Braunwald Professor of Medicine at Harvard Medical School, and Director of the Center for Cardiovascular Disease Prevention, at Brigham and Women’s Hospital, explains the role of high sensitivity C-reactive protein (hs-CRP) in detecting coronary inflammation and the opportunities to improve outcomes with targeted therapies.

Inflammation playing a much bigger role in heart disease evaluations

From new drug therapies and imaging technologies to updated prevention strategies, nearly every aspect of cardiovascular care is starting to embrace the value of coronary inflammation evaluations. Paul Ridker, MD, MPH, discussed the trend in a new interview.

Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, Explains a report showing socioeconomic factors are driving increased cardiovascular death rates, especially in younger adults, and urges action to address these health disparities.

Death from heart disease more common in rural areas—what can cardiologists do?

Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.

Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.

The lack of diversity in cardiac surgery trials may be harmful to patients

Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.

Video interview with Mario Gaudino on trends in cardiac surgery.

Veteran surgeon unpacks major changes in the world of cardiac surgery

Mario Gaudino, MD, PhD, spoke to Cardiovascular Business about minimally invasive procedures, the growing interest in clinical trials and other key trends in the world of cardiac surgery.

Video of neurologist Lucy He, MD, with the Alaska Stoke Coalition, discussing how they use AI and CT to revolutionize stroke care in the state.

Revolutionizing stroke care in rural Alaska with AI and CT imaging

Lucy He, MD, a neurosurgeon with the Alaska Stroke Coalition, explains how the state created an AI-based alert system to streamline the timely imaging diagnosis and transfer of stroke patients across the largest and most rural U.S. state.

Videos

Mechanical thrombectomy beats anticoagulation alone in STORM-PE

ACC raises red flags over telehealth, payment reform and the cardiologist shortage

Key takeaways for interventional cardiology from TCT 2025

The push to get 3D echo into the congenital operating room

Nuclear cardiology expands beyond perfusion imaging as it enters a new era